Literature DB >> 11923297

Characterization of oligopeptides that cross-react with carbohydrate-specific antibodies by real time kinetics, in-solution competition enzyme-linked immunosorbent assay, and immunological analyses.

Paul J Brett1, Harmale Tiwana, Ian M Feavers, Bambos M Charalambous.   

Abstract

Phage displaying random cyclic 7-mer, and linear 7-mer and 12-mer peptides at the N terminus of the coat protein, pIII, were panned with the murine monoclonal antibody, 9-2-L379 specific for meningococcal lipo-oligosaccharide. Five cyclic peptides with two sequence motifs, six linear 7-mers, and five linear 12-mers with different sequence motifs were identified. Only phage displaying cyclic peptides were specifically captured by and were antigenic for 9-2-L379. Monoclonal antibody 9-2-L379 exhibited "apparent" binding affinities to the cyclic peptides between 11 and 184 nm, comparable with lipo-oligosaccharide. All cyclic peptides competed with the binding of 9-2-L379 to lipo-oligosaccharide with EC(50) values in the range 10-105 microm, which correlated with their apparent binding affinities. Structural modifications of the cyclic peptides eliminated their ability to bind and compete with monoclonal antibody 9-2-L379. Mice (C3H/HeN) immunized with the cyclic peptide with optimal apparent binding affinity and EC(50) of competition elicited cross-reactive antibodies to meningococcal lipo-oligosaccharide with end point dilution serum antibody titers of 3200. Cyclic peptides were converted to T-cell-dependent immunogens without disrupting these properties by C-terminal biotinylation and complexing with NeutrAvidin. The data indicate that constrained peptides can cross-react with a carbohydrate-specific antibody with greater specificity than linear peptides, and critical to this specificity is their structural conformation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11923297     DOI: 10.1074/jbc.M200387200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Solid-phase extraction and purification of membrane proteins using a UV-modified PMMA microfluidic bioaffinity μSPE device.

Authors:  Katrina N Battle; Joshua M Jackson; Małgorzata A Witek; Mateusz L Hupert; Sally A Hunsucker; Paul M Armistead; Steven A Soper
Journal:  Analyst       Date:  2014-03-21       Impact factor: 4.616

2.  Characterization of a novel protective monoclonal antibody that recognizes an epitope common to Vibrio cholerae Ogawa and Inaba serotypes.

Authors:  Madushini N Dharmasena; Shelly J Krebs; Ronald K Taylor
Journal:  Microbiology (Reading)       Date:  2009-04-23       Impact factor: 2.777

3.  A peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120.

Authors:  Alfredo Menendez; Daniel A Calarese; Robyn L Stanfield; Keith C Chow; Chris N Scanlan; Renate Kunert; Herman Katinger; Dennis R Burton; Ian A Wilson; Jamie K Scott
Journal:  FASEB J       Date:  2008-01-15       Impact factor: 5.191

Review 4.  Phage display: selecting straws instead of a needle from a haystack.

Authors:  Miha Vodnik; Urska Zager; Borut Strukelj; Mojca Lunder
Journal:  Molecules       Date:  2011-01-19       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.